| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 713 | 1,240 | 1,135 | | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit | 713 | 1,240 | 1,135 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 1,104 | 1,805 | 1,766 | | Non Recurring |
-
| 128 |
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (391) | (693) | (631) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| | Earnings Before Interest And Taxes | (391) | (693) | (631) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (391) | (693) | (631) | | Income Tax Expense | 2 | 2 | 14 | | Minority Interest | 88 | 144 | 71 | | | | Net Income From Continuing Ops | (305) | (551) | (574) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items | 9 |
-
| 28 | | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (296) | (551) | (546) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($296) | ($551) | ($546) |
|
0.02% Nasdaq 
Income Statement
